THE RELATIONSHIP BETWEEN THE PARAMETERS OF MAGNETIC RESONANCE IMAGING OF THE BRAIN AND COGNITIVE FUNCTIONS IN POSTTRAUMATIC ENCEPHALOPATHY
Keywords:
post-traumatic encephalopathy, magnetic resonance imaging (MRI), cognitive disorders, MMSE scaleAbstract
Post-traumatic encephalopathy (PE) is a disease that occurs after traumatic brain injury and is accompanied by diffuse changes in the brain. After a traumatic brain injury, scarring, atrophic, and dystrophic changes develop in the tissues of the skull for 1 year, which lead to post-traumatic encephalopathy. Patients with PE have general cerebral complaints, neurological and intellectual-mnestic changes and neuropsychiatric disorders in the brain. In this article, special attention is paid to the relationship between cognitive changes and the results of MRI of the brain in patients with PE.
References
Неврологический вестник. 2020; T. LII(2): 67-71
The Chest X-Ray: a Survival Guide 1st Edition
Felson’s Principles of Chest Roentgenology: A programmed Text, 5th Edition
The unofficial Guide to Radiology :100 Practice Chest X-Rays
Визило Т.Л., Власова И.В. Клинико-неврологическая характеристика больных травматической энцефалопатией // Политравма. 2006. С. 68–72.
Лекции по черепно-мозговой травме: Учебное пособие / Под ред. В.В. Крылова. М., 2010.
Макаров А.Ю. Последствия черепно-мозговой травмы и их классификация // Неврол. журн. 2001. № 2.
Неврология и нейрохирургия: клин. рек. / Гл. ред. Е.И. Гусев, А.Н. Коновалов, А.Б. Гехт. Всероссийское общество неврологов. М.: ГЭОТАР-Медиа, 2008. 354 с.
ПутилинаМ.В., Радишевский М.В. Оптимизация программы реабилитации пациентов с черепно-мозговыми травмами // Русс. мед. журн. 2005. № 13. С. 22.
Чикина Е.С., Левин В.В. Черепно-мозговые травмы: применение современных ноотропных препаратов в острый период и при лечении посттравматической энцефалопатии // Русс. врач. 2005. № 11.
СейверД.Л. Цитиколин: новые данные о перспективном и широкодоступном средстве нейропротекции и нейрорепарации // ConsiliumMedicumUkraina. 2012. Т. 6, № 8. С. 29–33.
Alvarez-Sabin J., Roman G.С. Citicoline in vascular cognitive impairment and vascular dementia after stroke // Stroke. 2011. Vol. 42. P. S40–S43. 9. Alvarez-Sabin J., Roman G.С. The Role of citicoline in neuroprotection and neurorepair in ischemic stroke // Brain Sci. 2013. Vol. 3. P. 1395–1414.
BramlettH.M., DaltonD.W. Патофизиология ишемического и травматического поражения мозга: сходства и различия // Медицина неотложных состояний. 2006. № 4(5). С. 22–34.
Conant R., Schauss A.G. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature // Altern. Med. Rev. 2004. Vol. 9, № 1. P. 17–31. 12. Citicoline // Alternative Medicine Review. 2008. Vol. 13, № 1. P. 50–57.
Citicoline induces angiogenesis improving survival of vascular/human brain microvessel endothelial cells through pathways involving ERK1/2 and insulin receptor substrate-1 / Krupinski J., Abudawood M., Matou-Nasri S. et al. // Vasc. Cell. 2012. Vol. 4, № 20. doi: 10.1186/2045– 824X–4–20. 14. Davalos A., Secades J. Citicoline preclinical and clinical update 2009–2010 // Stroke. 2011. Vol. 42. P. S36–S9.
Fioravanti M., Yanagi M. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly // Cochrane Database Syst. Rev. 2004. Vol. 2. CD000269.
Grieb P. Neuroprotective properties of citicoline: facts, doubts and unresolved issues // CNS Drugs. 2014. Vol. 28, № 3. P. 185–193.
Qureshi I., Endres J.R. Citicoline: a novel therapeutic agent with neuroprotective, neuromodulatory, and neuroregenerative properties // Natural Medicine Journal. 2010. Vol. 2, № 6. P. 11–25.
Saver J.L. Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair // Rev. Neurol. Dis. 2008. Vol. 5, № 4. P. 167–177.
Secades J.J. Probably role of citicoline in stroke rehabilitation: review of the literature // Rev. Neurol. 2012. Vol. 54, № 3. P. 173–179.
Zweifler R.M. Membrane stabilizer: Citicoline // Current Medical Research and Opinions. 2002. Vol. 18 (suppl. 2). Р. 14–17
